Peter P. Gray's most recent trade in Jazz Pharmaceuticals plc was a trade of 3,075 Ordinary Shares done . Disclosure was reported to the exchange on Aug. 11, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharma PLC | Peter P. Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 3,075 | 17,309 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Peter P. Gray | Director | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 11 Aug 2023 | 1,241 | 16,068 (0%) | 0% | 138.2 | 171,455 | Ordinary Shares |
| Jazz Pharma PLC | Peter P. Gray | Director | Sale of securities on an exchange or to another person at price $ 158.00 per share. | 18 Aug 2022 | 8,000 | 14,234 (0%) | 0% | 158 | 1,264,000 | Ordinary Shares |
| Jazz Pharma PLC | Peter P. Gray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 8,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Peter P. Gray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.28 per share. | 18 Aug 2022 | 8,000 | 22,234 (0%) | 0% | 55.3 | 442,240 | Ordinary Shares |
| Jazz Pharma PLC | Peter P. Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,561 | 15,413 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Peter P. Gray | Director | Sale of securities on an exchange or to another person at price $ 152.32 per share. | 05 Aug 2022 | 1,179 | 14,234 (0%) | 0% | 152.3 | 179,588 | Ordinary Shares |